fda compounding semaglutide warning november 2025 Warns Novo Nordisk on Unreported Deaths FDA Warning Letter Breakdown: Sterility

supplements GLP-1 medications like semaglutide ( Ozempic and Wegovy) and tirzepatide ( Zepbound and Mounjaro) are FDA-approved prescription drugs specifically designed to manage type 2 diabetes and/or aid in weight loss

The piece was updated in November 2025

Diabetes drugs and stroke risk: Intensive versus conventional glucose-lowering strategies, and implications of recent cardiovascular outcome trials

Retatrutide Dosage: Pharmacokinetic and Pharmacodynamic Foundations Before selecting a retatrutide dosage , researchers must understand how this compound behaves in biological systems

SAFETY & MONITORING ESSENTIALS: GI effects (nausea, vomiting, diarrhea) typically transient

A: GLP-1 is projected to grow in every market we are studying